Skip to content
10-Q

Quarterly Report

Bio Essence Corp BIOE

0001213900-24-098180

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 14, 2024 38.01M sh
Long Term Debt Q3 2024 · Sep 30, 2024 $56.79K
Cash And Equivalents Q3 2024 · Sep 30, 2024 $29.82K
Current Liabilities Q3 2024 · Sep 30, 2024 $3.07M
Current Liabilities Q3 2024 · Dec 31, 2023 $2.45M
Total Liabilities Q3 2024 · Sep 30, 2024 $3.66M
Total Liabilities Q3 2024 · Dec 31, 2023 $4.42M
Current Assets Q3 2024 · Sep 30, 2024 $715.58K
Current Assets Q3 2024 · Dec 31, 2023 $300K
Total Assets Q3 2024 · Sep 30, 2024 $715.97K
Total Assets Q3 2024 · Dec 31, 2023 $2.76M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.03
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.03
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.02
Eps Basic Q3 2024 · Sep 30, 2024 −$0.03
Eps Basic Q3 2024 · Sep 30, 2024 −$0.03
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 −$0.02
Capex Q3 2024 · Sep 30, 2023 $3.61K
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$821.58K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$1.47M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$1.15M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$3.42M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$3.24M
Sga Expense restated Q3 2024 · Sep 30, 2023 $82.64K
Sga Expense restated Q3 2024 · Sep 30, 2023 $150.11K
Net Income Q3 2024 · Sep 30, 2023 −$314.84K
Net Income Q3 2024 · Sep 30, 2023 −$778.19K
Net Income Q3 2024 · Jun 30, 2023 −$284.52K
Net Income Q3 2024 · Mar 31, 2023 −$178.84K
Operating Income restated Q3 2024 · Sep 30, 2023 −$82.64K
Operating Income restated Q3 2024 · Sep 30, 2023 −$150.11K